ANTHONY SOLHJOO: Open Payments
NPI 1447024872 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $1,330 · 2025 $1,036
Food & beverage: $937Education: $99
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 2 | $259 |
| UCB, Inc. | 1 | $161 |
| GENZYME CORPORATION | 2 | $142 |
| Janssen Scientific Affairs, LLC | 1 | $140 |
| Lilly USA, LLC | 2 | $133 |
| Janssen Biotech, Inc. | 1 | $99 |
| Arcutis Biotherapeutics, Inc. | 1 | $88 |
| ABBVIE INC. | 1 | $14 |
Products named: ADBRY, TREMFYA, Bimzelx, EBGLYSS, Zoryve, DUPIXENT, RINVOQ.
Industry payments across TX — which companies pay providers there.
